412 related articles for article (PubMed ID: 33097974)
41. Automatic lesion detection and segmentation of 18F-FET PET in gliomas: A full 3D U-Net convolutional neural network study.
Blanc-Durand P; Van Der Gucht A; Schaefer N; Itti E; Prior JO
PLoS One; 2018; 13(4):e0195798. PubMed ID: 29652908
[TBL] [Abstract][Full Text] [Related]
42. Multi-scale feature similarity-based weakly supervised lymphoma segmentation in PET/CT images.
Huang Z; Guo Y; Zhang N; Huang X; Decazes P; Becker S; Ruan S
Comput Biol Med; 2022 Dec; 151(Pt A):106230. PubMed ID: 36306574
[TBL] [Abstract][Full Text] [Related]
43. Metabolic tumor burden on baseline
Chen S; He K; Feng F; Wang S; Yin Y; Fu H; Wang H
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1830-1839. PubMed ID: 31187163
[TBL] [Abstract][Full Text] [Related]
44. Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients.
Meignan M; Sasanelli M; Casasnovas RO; Luminari S; Fioroni F; Coriani C; Masset H; Itti E; Gobbi PG; Merli F; Versari A
Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1113-22. PubMed ID: 24570094
[TBL] [Abstract][Full Text] [Related]
45. Deep learning-based automatic delineation of anal cancer gross tumour volume: a multimodality comparison of CT, PET and MRI.
Groendahl AR; Moe YM; Kaushal CK; Huynh BN; Rusten E; Tomic O; Hernes E; Hanekamp B; Undseth C; Guren MG; Malinen E; Futsaether CM
Acta Oncol; 2022 Jan; 61(1):89-96. PubMed ID: 34783610
[TBL] [Abstract][Full Text] [Related]
46. Baseline
Aide N; Fruchart C; Nganoa C; Gac AC; Lasnon C
Eur Radiol; 2020 Aug; 30(8):4623-4632. PubMed ID: 32248365
[TBL] [Abstract][Full Text] [Related]
47. Automatic segmentation and applicator reconstruction for CT-based brachytherapy of cervical cancer using 3D convolutional neural networks.
Zhang D; Yang Z; Jiang S; Zhou Z; Meng M; Wang W
J Appl Clin Med Phys; 2020 Oct; 21(10):158-169. PubMed ID: 32991783
[TBL] [Abstract][Full Text] [Related]
48. Baseline circulating tumour DNA and total metabolic tumour volume as early outcome predictors in aggressive large B-cell lymphoma. A real-world 112-patient cohort.
Le Goff E; Blanc-Durand P; Roulin L; Lafont C; Loyaux R; MBoumbae DL; Benmaad I; Claudel A; Poullot E; Robe C; Gricourt G; Aissat A; Copie-Bergman C; Lemonnier F; Gaulard P; Itti E; Haioun C; Delfau-Larue MH
Br J Haematol; 2023 Jul; 202(1):54-64. PubMed ID: 37038217
[TBL] [Abstract][Full Text] [Related]
49. Total tumor burden in lymphoma - an evolving strong prognostic parameter.
Meignan M; Cottereau AS; Specht L; Mikhaeel NG
Br J Radiol; 2021 Nov; 94(1127):20210448. PubMed ID: 34379496
[TBL] [Abstract][Full Text] [Related]
50. Fully automatic multi-organ segmentation for head and neck cancer radiotherapy using shape representation model constrained fully convolutional neural networks.
Tong N; Gou S; Yang S; Ruan D; Sheng K
Med Phys; 2018 Oct; 45(10):4558-4567. PubMed ID: 30136285
[TBL] [Abstract][Full Text] [Related]
51. A multi-label CNN model for the automatic detection and segmentation of gliomas using [
Rahimpour M; Boellaard R; Jentjens S; Deckers W; Goffin K; Koole M
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2441-2452. PubMed ID: 36933075
[TBL] [Abstract][Full Text] [Related]
52. An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients.
Ferrández MC; Golla SSV; Eertink JJ; de Vries BM; Lugtenburg PJ; Wiegers SE; Zwezerijnen GJC; Pieplenbosch S; Kurch L; Hüttmann A; Hanoun C; Dührsen U; de Vet HCW; ; Zijlstra JM; Boellaard R
Sci Rep; 2023 Aug; 13(1):13111. PubMed ID: 37573446
[TBL] [Abstract][Full Text] [Related]
53. Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden.
Leccisotti L; Maccora D; Malafronte R; D'Alò F; Maiolo E; Annunziata S; Rufini V; Giordano A; Hohaus S
J Cancer Res Clin Oncol; 2023 Jul; 149(7):2783-2791. PubMed ID: 35779106
[TBL] [Abstract][Full Text] [Related]
54. Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma.
Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
Eur J Haematol; 2015 Jun; 94(6):532-9. PubMed ID: 25311082
[TBL] [Abstract][Full Text] [Related]
55. Influence of the methodological aspects of the dichotomization of total metabolic tumor volume measured through baseline fluorine-18 fluorodeoxyglucose PET on survival prediction in lymphoma.
Lue KH; Chen YH; Wu YF; Liu SH
Nucl Med Commun; 2023 Jan; 44(1):74-80. PubMed ID: 36514929
[TBL] [Abstract][Full Text] [Related]
56. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
Ding CY; Guo Z; Sun J; Yang WP; Li TR
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
[No Abstract] [Full Text] [Related]
57. Whole liver segmentation based on deep learning and manual adjustment for clinical use in SIRT.
Tang X; Jafargholi Rangraz E; Coudyzer W; Bertels J; Robben D; Schramm G; Deckers W; Maleux G; Baete K; Verslype C; Gooding MJ; Deroose CM; Nuyts J
Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2742-2752. PubMed ID: 32314026
[TBL] [Abstract][Full Text] [Related]
58. Fully automated 3D segmentation and separation of multiple cervical vertebrae in CT images using a 2D convolutional neural network.
Bae HJ; Hyun H; Byeon Y; Shin K; Cho Y; Song YJ; Yi S; Kuh SU; Yeom JS; Kim N
Comput Methods Programs Biomed; 2020 Feb; 184():105119. PubMed ID: 31627152
[TBL] [Abstract][Full Text] [Related]
59. Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network.
Kostyszyn D; Fechter T; Bartl N; Grosu AL; Gratzke C; Sigle A; Mix M; Ruf J; Fassbender TF; Kiefer S; Bettermann AS; Nicolay NH; Spohn S; Kramer MU; Bronsert P; Guo H; Qiu X; Wang F; Henkenberens C; Werner RA; Baltas D; Meyer PT; Derlin T; Chen M; Zamboglou C
J Nucl Med; 2021 Jun; 62(6):823-828. PubMed ID: 33127624
[TBL] [Abstract][Full Text] [Related]
60. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
